<code id='285A520E07'></code><style id='285A520E07'></style>
    • <acronym id='285A520E07'></acronym>
      <center id='285A520E07'><center id='285A520E07'><tfoot id='285A520E07'></tfoot></center><abbr id='285A520E07'><dir id='285A520E07'><tfoot id='285A520E07'></tfoot><noframes id='285A520E07'>

    • <optgroup id='285A520E07'><strike id='285A520E07'><sup id='285A520E07'></sup></strike><code id='285A520E07'></code></optgroup>
        1. <b id='285A520E07'><label id='285A520E07'><select id='285A520E07'><dt id='285A520E07'><span id='285A520E07'></span></dt></select></label></b><u id='285A520E07'></u>
          <i id='285A520E07'><strike id='285A520E07'><tt id='285A520E07'><pre id='285A520E07'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:167
          Christopher Viehbacher on stage at the 2023 STAT Summit.
          Biogen CEO Christopher Viehbacher STAT

          Two years after a big scientific swing nearly pushed Biogen to the brink, CEO Christopher Viehbacher is embarking on a corporate rethink, one that balances Biogen’s characteristic risky bets with a frank commitment to pragmatism.

          Speaking at the STAT Summit in Boston on Thursday, Viehbacher said his Biogen predecessors fell off track through a few unsound investments and an all-or-nothing bet on Aduhelm, the Alzheimer’s disease treatment that became a pharmaceutical cautionary tale. Viehbacher, one year into his tenure at the storied company, said Biogen’s future will rely on taking a more disciplined approach to risk.

          advertisement

          “There’s a huge amount of pride inside the company that we go after problems other people don’t,” Viehbacher said, “but at the end of the day you also have to get medicines through the pipeline to benefit patients, and that’s why we’re expanding the aperture of what we’re doing in R&D.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships
          Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

          1:03U.S.Marineswiththe26thMarineExpeditionaryUnitMaritimeSpecialPurposeForce,preparetodeparttheUSSBa

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          China sends large group of warplanes, navy ships towards Taiwan in forceful display

          FILE-InthisfilephotoreleasedbytheTaiwanMinistryofNationalDefense,aChinesePeople'sLiberationArmyH-6bo